As the cost of sequencing continues to drop, the throughput and complexity of NGS assays have risen precipitously. At the same time, the types of samples being used for these assays have expanded as researchers find value in studying low-input, degraded, biological samples, such as cell-free DNA (cfDNA). In this webinar, Integrated DNA Technologies presents a complete workflow for effective analysis of <1% variant allele frequency (VAF) in cfDNA.
In this webinar, we will:
Clinical Lab Manager needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime.
For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our privacy policy by clicking here.
© 2020 CLINICAL LAB MANAGER. ALL RIGHTS RESERVED.